There are currently 1013 clinical trials in Portland, Oregon looking for participants to engage in research studies. Trials are conducted at various facilities, including Oregon Health & Science University, Oregon Health and Science University /ID# 216891, Providence Portland Medical Center and Providence Saint Vincent Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Improving Sleep, Sleep-related Outcomes, and Biomarkers in Veterans
Recruiting
The primary purpose of this project is to determine the effect of morning bright light therapy (MBLT) on sleep in Veterans with traumatic brain injury (TBI). Secondarily, the project aims to identify blood-based brain biomarkers (BBBM) associated with sleep in Veterans. Specific Aim 1. Determine the effect of MBLT on sleep quality in Veterans (primary outcome). Specific Aim 2. Determine the effect of MBLT on downstream effectors of improved sleep, including cognition, mood, and quality of life... Read More
Gender:
ALL
Ages:
Between 18 years and 88 years
Trial Updated:
04/04/2022
Locations: Portland VA Medical Center, Portland, Oregon
Conditions: Traumatic Brain Injury
Pilot Study of BCAA on Sleep
Recruiting
Individuals will be recruited from the VA Portland Health Care System and the community affiliated with Oregon Health \& Science University. Traumatic brain injury status will be assessed as a contributing factor. Subjects will be randomized to one of 3 groups (BCAA or one of 2 placebo conditions) and instructed to consume study product twice daily for 21 days. Self-report questionnaires, wrist actigraphy, pressure pain testing, and cognitive function will be assessed pre and post the experiment... Read More
Gender:
ALL
Ages:
Between 18 years and 89 years
Trial Updated:
04/04/2022
Locations: VA Portland Health Care System, Portland, Oregon
Conditions: Sleep Disorder, Traumatic Brain Injury
Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis
Recruiting
The goal of this study is to determine the safety and tolerability or efficacy of adjunctive treatments (including rosuvastatin 20 mg daily) in combination with standard anticoagulation therapy (Factor Xa inhibitors) in patients with lower extremity deep vein thrombosis (DVT). The efficacy of adjunctive treatments to prevent the development of post thrombotic syndrome (PTS) after DVT will be evaluated.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
10/14/2021
Locations: VA Portland Health Care System (VAPORHCS), Portland, Oregon
Conditions: Post-thrombotic Syndrome, Deep Vein Thrombosis Leg
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
Recruiting
The purpose of the study is to compare the efficacy of parsaclisib when combined with ruxolitinb versus placebo combined with ruxolitinib in participants with myelofibrosis.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/24/2021
Locations: Kaiser Permanente - Northwest, Portland, Oregon
Conditions: Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia Vera Myelofibrosis
Augmentation of Limb Perfusion With Contrast Ultrasound
Recruiting
Our laboratory has discovered that ultrasound (US) imaging together with clinically approved microbubble ultrasound contrast agents can augment limb tissue perfusion. These observations have been made in mice with and without peripheral artery disease (PAD), and also in humans where high power contrast enhanced ultrasound (CEU) was used to measure perfusion but was found also to augment perfusion by almost 2-fold. The latter human studies were performed with ultrasound protocols designed for per... Read More
Gender:
ALL
Ages:
Between 19 years and 99 years
Trial Updated:
08/21/2018
Locations: OHSU, Portland, Oregon
Conditions: Peripheral Arterial Disease